Clinical outcomes in COVID‐19 patients treated with tocilizumab: An individual patient data systematic review

Antwi‐Amoabeng, Daniel; Kanji, Zahara; A. Ford, Brent; D. Beutler, Bryce; S. Riddle, Mark; Siddiqui, Faisal

doi:10.1002/jmv.26038

Public

Clinical outcomes in COVID‐19 patients treated with tocilizumab: An individual patient data systematic review

Published in Journal of Medical Virology • May 21, 2020

Authors:

Daniel Antwi‐Amoabeng

Zahara Kanji

Brent A. Ford

Abstract

BACKGROUND: Current evidence suggests an important role of the interleukin-6 (IL-6) pathway in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related cytokine release storm in severely ill coronavirus disease 2019 (COVID-19) patients. Inhibition of the IL-6 pathway with tocilizumab has...

Subject

Tocilizumab

Medicine

Clinical endpoint

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!